PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 102 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $42,000 | -70.0% | 40,018 | -16.0% | 0.00% | – |
| Q4 2015 | $140,000 | -6.7% | 47,618 | 0.0% | 0.00% | – |
| Q3 2015 | $150,000 | -46.8% | 47,618 | 0.0% | 0.00% | – |
| Q2 2015 | $282,000 | -31.1% | 47,618 | +24.6% | 0.00% | – |
| Q1 2015 | $409,000 | +13.9% | 38,218 | 0.0% | 0.00% | – |
| Q4 2014 | $359,000 | +80.4% | 38,218 | +47.7% | 0.00% | – |
| Q3 2014 | $199,000 | -40.1% | 25,868 | -30.0% | 0.00% | – |
| Q2 2014 | $332,000 | +87.6% | 36,968 | +11.8% | 0.00% | – |
| Q1 2014 | $177,000 | +68.6% | 33,068 | -20.8% | 0.00% | – |
| Q4 2013 | $105,000 | -11.0% | 41,768 | -3.5% | 0.00% | – |
| Q3 2013 | $118,000 | -25.8% | 43,268 | -1.6% | 0.00% | – |
| Q2 2013 | $159,000 | – | 43,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |